Implementation of Multiple Micronutrient Supplementation (MMS) for Pregnant Women in Uganda

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age0-80
SponsorJohns Hopkins Bloomberg School of Public Health

About this trial

The objective of this research is to understand how antenatal multiple micronutrient supplements (MMS) can be effectively implemented and scaled within the Uganda national health system context to support improved maternal nutrition and birth outcomes. Formative research has been conducted to design the implementation strategies that will be tested in this second phase of the study. The objectives are to:

* Describe the implementation of the MMS intervention (which consists of MMS product, a social behavior change communication (SBCC) strategy, capacity building, MMS supply chain support, monitoring, and evaluation) and explore acceptability, feasibility, fidelity, coverage, and potential for sustainability. * Determine the effect of dispensing MMS in different bottle counts on MMS adherence and ANC attendance among pregnant women. * Determine the cost and budget impact of MMS intervention implementation integrated in the Ugandan ANC service delivery system

Eligibility criteria

Qualifiers

≤24 weeks of amenorrhea/gestation as verified by health professionals

Attending first ANC visit at government or PNFP health facilities.

Accepted to take MMS at first ANC visit

Disqualifiers

Pregnant women with pre-existing hematological conditions such as sickle cell anemia, thalassemia, hemochromatosis.

Pregnant women planning to relocate outside the study district during the study period.

Currently pregnant woman or a woman who is not more than 8 weeks postpartum.

Received MMS at an ANC visit at least 3 months ago or more.

Trial design

Treatments tested in this trial

  • Multiple Micronutrient Supplement (MMS) - dispensed in six 30-count bottles
  • Multiple Micronutrient Supplement (MMS) - dispensed in one 180-count bottle
  • Multiple Micronutrient Supplement (MMS) - dispensed in two 90-count bottles

Treatment groups

4,077 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Johns Hopkins Bloomberg School of Public Health

Lead sponsor

Vitamin Angels

Collaborator

UNICEF

Collaborator

Child and Family Foundation of Uganda

Collaborator

Kirk Humanitarian

Collaborator